Decoding the dopamine transporter imaging for the differential diagnosis of parkinsonism using deep learning
-
Published:2022-05-19
Issue:8
Volume:49
Page:2798-2811
-
ISSN:1619-7070
-
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
-
language:en
-
Short-container-title:Eur J Nucl Med Mol Imaging
Author:
Zhao Yu,Wu Ping,Wu Jianjun,Brendel Matthias,Lu Jiaying,Ge Jingjie,Tang Chunmeng,Hong Jimin,Xu Qian,Liu Fengtao,Sun Yimin,Ju Zizhao,Lin Huamei,Guan Yihui,Bassetti Claudio,Schwaiger Markus,Huang Sung-Cheng,Rominger Axel,Wang Jian,Zuo Chuantao,Shi Kuangyu
Abstract
Abstract
Purpose
This work attempts to decode the discriminative information in dopamine transporter (DAT) imaging using deep learning for the differential diagnosis of parkinsonism.
Methods
This study involved 1017 subjects who underwent DAT PET imaging ([11C]CFT) including 43 healthy subjects and 974 parkinsonian patients with idiopathic Parkinson’s disease (IPD), multiple system atrophy (MSA) or progressive supranuclear palsy (PSP). We developed a 3D deep convolutional neural network to learn distinguishable DAT features for the differential diagnosis of parkinsonism. A full-gradient saliency map approach was employed to investigate the functional basis related to the decision mechanism of the network. Furthermore, deep-learning-guided radiomics features and quantitative analysis were compared with their conventional counterparts to further interpret the performance of deep learning.
Results
The proposed network achieved area under the curve of 0.953 (sensitivity 87.7%, specificity 93.2%), 0.948 (sensitivity 93.7%, specificity 97.5%), and 0.900 (sensitivity 81.5%, specificity 93.7%) in the cross-validation, together with sensitivity of 90.7%, 84.1%, 78.6% and specificity of 88.4%, 97.5% 93.3% in the blind test for the differential diagnosis of IPD, MSA and PSP, respectively. The saliency map demonstrated the most contributed areas determining the diagnosis located at parkinsonism-related regions, e.g., putamen, caudate and midbrain. The deep-learning-guided binding ratios showed significant differences among IPD, MSA and PSP groups (P < 0.001), while the conventional putamen and caudate binding ratios had no significant difference between IPD and MSA (P = 0.24 and P = 0.30). Furthermore, compared to conventional radiomics features, there existed average above 78.1% more deep-learning-guided radiomics features that had significant differences among IPD, MSA and PSP.
Conclusion
This study suggested the developed deep neural network can decode in-depth information from DAT and showed potential to assist the differential diagnosis of parkinsonism. The functional regions supporting the diagnosis decision were generally consistent with known parkinsonian pathology but provided more specific guidance for feature selection and quantitative analysis.
Funder
National Natural Science Foundation of China
Ministry of Science and Technology of the People's Republic of China
Science and Technology Commission of Shanghai Municipality
National Major Science and Technology Projects of China
Youth Medical Talents - Medical Imaging Practitioner Program by Shanghai Municipal Health Commission and Shanghai Medical and Health Development Foundation
Shanghai Sailing Program by Shanghai Science and Technology Committee
Medical Innovation Research Project funded by Shanghai Science and Technology Commission
Swiss National Science Foundation
Jacques und Gloria Gossweiler-Stiftung
Siemens Healthineers
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine
Reference40 articles.
1. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861–70.
2. de la Fuente-Fernández R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology. 2012;78:696–701.
3. Albert NL, Unterrainer M, Diemling M, Xiong G, Bartenstein P, Koch W, et al. Implementation of the European multicentre database of healthy controls for [123 I] FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes. Eur J Nucl Med Mol Imaging. 2016;43:1315–22.
4. Isaias IU, Marotta G, Pezzoli G, Sabri O, Hesse S. [123I] FP-CIT SPECT in atypical degenerative parkinsonism. Imaging in Medicine. 2012;4:411–21.
5. Meyer PT, Hellwig S, Amtage F. Differential Diagnostics of Neurodegenerative Parkinsonian Syndromes with Nuclear Medicine Procedures. Der Nuklearmediziner. 2012;35:109–23.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献